Srinivasan has worked across various finance roles in her career spanning 16 years
The Bengaluru-based fresh meat company has over 500 Licious stores opening across 20 cities in the next five years as it targets operating profit by the end of the current financial year
Akella explained the distribution of these service touchpoints between main urban centres and other regions
There were also suggestions that FTAs can be used as tools to enhance supply chain resilience, ensuring stability and sustainability in trade relationships
India needs a strategy that goes beyond setting up graphical processing units and focuses on leveraging its abundant talent
The company posted a 4.5 per cent year-on-year increase in revenue from operations to Rs 2,426 crore during the quarter ended March 31, 2024, as against Rs 2,321 crore in the same period last year
The research findings are based on the provisions of India's Digital Personal Data Protection (DPDP) Act that was passed by both the houses of parliament in August 2023
Share has risen as a percentage of net sales
In a video interview, Amith Singhee talked about Research Lab's role and generative artificial intelligence (GenAI). Edited excerpts
Biscuits to be the next focus for the company
A year ago, Adani Enterprises and Adani Energy Solutions had sought board and shareholder approval for a similar proposal of raising up to Rs 12,500 crore and Rs 8,500 crore, respectively
This trend underscores that Air India and Vistara, both Tata Group airlines and the only carriers in India with business class offerings, are capitalizing on the opportunity to charge premium prices
The quarter saw the highest ever sales and margins for Ashok Leyland
Wins a copper mine in auctions, scouts for nickel, lignite cobalt in India auctions.
At an operational level, Torrent Pharma's earnings before interest, tax, depreciation and amortisation (Ebitda) increased by 21 per cent to Rs 883 crore
Total business premium for the year ending March 31, 2024 grew by 62 per cent to Rs 1,871 crore
The merger agreement between Sun Pharma and Taro was approved by an affirmative vote of Taro shareholders at an extraordinary general meeting and an ordinary class meeting on May 22
Sebi has also proposed to make the disclosures for value chain partners voluntary for the first year instead of comply or explain basis
AZAD will start delivering fully integrated advanced turbo engines by early 2026
Speaking to Sohini Das over a video interview from the US, Abhay Gandhi, CEO, North America of Sun Pharma outlines his plan for the company's specialty business